Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,125,160    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,064,010      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 19 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-29 4 OE $37.46 $187,300 D/D 5,000 339,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-05 4 OE $37.46 $374,600 D/D 10,000 345,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-06 4 OE $37.46 $749,200 D/D 20,000 355,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-10-31 4 AS $37.68 $151,856 D/D (4,000) 174,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-02-29 4 S $37.91 $805,798 D/D (21,142) 4,071 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-09-14 4 S $37.91 $151,628 D/D (4,000) 177,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-03-04 4 S $38.00 $152,000 D/D (4,000) 7,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Business Officer   •       •      –    2012-05-12 5 D $38.00 $297,160 D/D (7,820) 149,446 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-11 4 S $38.01 $969,656 D/D (25,500) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-03-03 4 S $38.10 $76,239 D/D (2,000) 11,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-14 4 S $38.13 $571,893 D/D (15,000) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-09 4 S $38.39 $310,031 D/D (8,000) 8,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-16 4 AS $38.47 $577,370 D/D (15,000) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-29 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-30 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-13 4 OE $38.59 $2,050,094 D/D 53,125 376,493 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-28 4 OE $38.59 $385,900 D/D 10,000 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-29 4 OE $38.59 $385,900 D/D 10,000 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-01-05 4 OE $38.59 $385,900 D/D 10,000 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-02-15 4 OE $38.59 $385,900 D/D 10,000 236,494 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 OE $38.59 $578,850 D/D 15,000 279,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-16 4 OE $38.59 $578,850 D/D 15,000 311,106 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-20 4 OE $38.59 $385,900 D/D 10,000 300,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-23 4 OE $38.59 $385,900 D/D 10,000 300,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-24 4 OE $38.59 $385,900 D/D 10,000 300,031 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19  20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 19 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us